Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population

Abstract

Background

The island of Sardinia features a high incidence of multiple sclerosis (MS) characterized by early age at onset and a progressively increasing trend. The current study was aimed at examining variations in human leukocyte antigen–risk genotypes occurring over time in a cohort of patients.

Methods

Susceptible and neutral DRB1-DQB1 genotypes were identified in 1660 patients. Age at onset was established in 1436 patients divided into two cohorts, an older cohort (subjects born before 1949, N = 233) and a younger one (subjects born from 1960 to 1989, N = 850). Patients from the older cohort were randomly assigned to patients of the same sex from the younger cohort, matched for age at onset. The final sample included 170 pairs. Logistic conditional analysis was performed to determine the probability of a neutral genotype in both cohorts. Kaplan–Meier analysis was applied to ascertain the influence of predisposing and neutral genotypes in age at onset for both cohorts.

Findings

The probability of carrying a neutral genotype was 1.76-fold higher in the younger than in the older cohort (P = 0.02) and 3.67-fold higher in men (P = 0.005). Kaplan–Meier analysis revealed an earlier age at onset in patients of the young cohort carrying the predisposing genotype (P = 0.004).

Interpretation

In the Sardinian population, an environment more prone and propitious to autoimmunity may contribute toward the rising incidence of MS or anticipate overt manifestation of the disease in genetically predisposed subjects.

Keywords

environment genes HLA multiple sclerosis

Get full access to this article

View all access options for this article.

References

1 Compston A Coles A . Multiple sclerosis. Lancet 2008; 372: 1502–1517.

2 Haines JL Terwedow HA Burgess K . Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet 1998; 7: 1229–1234.

3 Barcellos LF Oksenberg JR Begovich AB . HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003; 72: 710–716.

4 Stewart GJ Teutsch SM Castle M Heard RN Bennetts BH . HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients. Eur J Immunogenet 1997; 24: 81–92.

5 Laaksonen M Pastinen T Sjoroos M . HLA class II associated risk and protection against multiple sclerosis-a Finnish family study. J Neuroimmunol 2002; 122: 140–145.

6 Chataway J Feakes R Coraddu F . The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 1998; 121(Pt 10): 1869–1887.

7 Oksenberg JR Barcellos LF Cree BA . Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004; 74: 160–167.

8 Marrosu MG Murru R Murru MR . Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 2001; 10: 2907–2916.

9 Ascherio A Munger KL . Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007; 61: 288–299.

10.

10 Ascherio A Munger KL . Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 2007; 61: 504–513.

11.

11 Willer CJ Dymet DA Risch NJ Sadovnick AD Ebers GC . Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 2003; 100: 12877–12882.

12.

12 Orton SM Herrera BM Yee IM . Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006; 5: 932–936.

13.

13 Islam T Gauderman WJ Cozen W Hamilton AS Burnett ME Mack TM . Differential twin concordance for multiple sclerosis by latitude of birthplace. Ann Neurol 2006; 60: 56–64.

14.

14 Compston DAS . Distribution of multiple sclerosis. In: DAS Compston G Ebers H Lassman I McDonald B Matthews H Wekerle , (eds), McAlpine multiple sclerosis. 3rd ed. London: Churchill Livingstone; 1998. pp. 63–100.

15.

15 Granieri E Casetta I Govoni V . The increasing incidence and prevalence of MS in a Sardinian province. Neurology 2000; 55: 842–847.

16.

16 Marrosu MG Lai M Cocco E . Genetic factors and the founder effect explain familial MS in Sardinia. Neurology 2002; 58: 283–288.

17.

17 Pugliatti M Sotgiu S Solinas G . Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurol Scand 2001; 103: 20–26.

18.

18 Cocco E Sardu C Lai M Spinicci G Contu P Marrosu MG . Anticipation of age at onset in multiple sclerosis. A Sardinian cohort study. Neurology 2004; 62: 1794–1798.

19.

19 McDonald WI Compston A Edan G . Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.

20.

20 Polman CH Reingold SC Edan G . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005; 58: 840–846.

21.

21 Marrosu MG Motzo C Murru R . The co-inheritance of diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone. Hum Mol Genet 2004; 13: 2919–2924.

22.

22 Lawless JF . Statistical models and methods for lifetime data. New York: Wiley; 1982. pp. 343–400.

23.

23 Gale EAM . The rise of childhood type 1 diabetes in the twentieth century. Diabetes 2002; 51: 3353–3361.

24.

24 Alonso A Hernan MA . Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008; 71: 129–135.

25.

25 Bach JF . The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911–931.

26.

26 Gilden DH . Infectious causes of multiple sclerosis. Lancet Neurol 2005; 4: 195–202.

27.

27 Correale J Farez M . Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007; 61: 97–108.

28.

28 Sewell D Qing Z Reinke E . Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003; 15: 59–69.

29.

29 La Flamme AC Ruddenklau K Backstrom BT . Schistosomiasis decreases central nervous inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003; 71: 4996–5004.

30.

30 Lipton HL Liang Z Hertzler S Son KN . A specific viral cause of multiple sclerosis: one virus, one disease. Ann Neurol 2007; 61: 514–523.

31.

31 Serafini B Rosicarelli B Franciotta D . Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204: 2899–2912.